Metabolic Dysfunction-Associated Steatohepatitis (MASH) Research Samples
56 Results
1 - 56 of 56 total samples.
Advanced Data View:
1 - 56 of 56 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 1 Detail | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Elastography Result | Comorbidities | Smoking Status | Alcohol Consumption | HIV-I/II, Hepatitis B, Hepatitis C Test Results | Ultrasound Result | Diagnosis | HIV-I/II result | Hepatitis B result | Hepatitis C result | CT / MRI results |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BF19871139 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 39 Y | F | White | <-70C | 01-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2023 | Height | 165 cm | Weight | 97 kg | $400.00 | Liver stiffness, as measured by elastography, is consistent with METAVIR F1 - F2 stage fibrosis 10-Sep-2025 | Chronic pancreatitis; Obesity class II 2020; 2023 | Current Cigarette Use (15/day, 10 years) | Never used | Negative | |||||||||
| BF19871140 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 50 Y | F | White | <-70C | 01-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2024 | Height | 163 cm | Weight | 101 kg | $400.00 | Liver stiffness, as measured by elastography, is consistent with METAVIR F1 - F2 stage fibrosis 9-Sep-2025 | Obesity class II; Diabetes mellitus type 2 2010; 2016 | Never used | Never used | Negative | |||||||||
| BF19871141 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 44 Y | M | White | <-70C | 08-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 8-Aug-2025 | Height | 190 cm | Weight | 130 kg | $400.00 | Liver stiffness, as measured by elastography, is consistent with METAVIR F1 stage fibrosis 8-Aug-2025 | Obesity class II 2011 | Previous Cigarette Use (15/day, 5 years, Quit in 2011) | Previous Use (2/day, 5 years, Quit in 2011) | Negative | |||||||||
| BF19871142 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 60 Y | M | White | <-70C | 02-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2024 | Height | 184 cm | Weight | 115 kg | $400.00 | Liver stiffness, as measured by elastography, is consistent with METAVIR F2 stage fibrosis 13-Oct-2025 | Diabetes mellitus type 2 2017 | Never used | Never used | Negative | |||||||||
| BF19871143 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 55 Y | M | White | <-70C | 08-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2024 | Height | 170 cm | Weight | 127 kg | $400.00 | Liver stiffness, as measured by elastography, is consistent with METAVIR F2 stage fibrosis 6-Oct-2025 | Obesity class III; Diabetes mellitus type 2 2010; 2020 | Never used | Never used | Negative | |||||||||
| BF19871145 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 12.00 | $400.00 | 19 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 5-Oct-2025 | Height | 182 cm | Weight | 88 kg | $400.00 | Mean liver stiffness: 6.4 kPa (F1 by METAVIR) 5-Oct-2025 | N/A | Never used | Never used | Negative | |||||||||
| BF19871146 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 44 Y | M | White | <-70C | 07-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 7-Oct-2025 | Height | 170 cm | Weight | 130 kg | $400.00 | Sonographic signs of chronic hepatitis, consistent with METAVIR F2 fibrosis, and severe hepatic steatosis 7-Oct-2025 | Obesity class III; Hypertension 2019; 2020 | Never used | Never used | Negative | |||||||||
| BF19871150 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 54 Y | M | White | <-70C | 09-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 9-Oct-2025 | Height | 164 cm | Weight | 68 kg | $400.00 | Sonographic signs of chronic hepatitis, consistent with METAVIR F3 fibrosis, and severe hepatic steatosis 9-Oct-2025 | Chronic obstructive pulmonary disease; Hypertension; Ischemic heart disease 2018; 2020; 2020 | Current Cigarette Use (25/day, 18 years) | Never used | Negative | |||||||||
| BF19871151 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 53 Y | M | White | <-70C | 16-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2021 | Height | 176 cm | Weight | 86 kg | $400.00 | Mean liver stiffness: 6.56 kPa (F1-2 by METAVIR) 16-Oct-2025 | Hypertension; Ischemic heart disease 2020; 2022 | Never used | Never used | Negative | |||||||||
| BF19871153 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 12.00 | $400.00 | 68 Y | M | White | <-70C | 10-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 10-Oct-2025 | Height | 180 cm | Weight | 110 kg | $400.00 | Ultrasound signs of diffuse liver changes, consistent with METAVIR F1 fibrosis, and moderate hepatic steatosis 10-Oct-2025 | Hypertension; Ischemic heart disease; Diabetes mellitus type 2 2013; 2016; 2019 | Never used | Never used | Negative | |||||||||
| BF19871168 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 13.00 | $400.00 | 43 Y | M | White | <-70C | 01-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 1-Oct-2025 | Height | 182 cm | Weight | 90 kg | $400.00 | Mean liver stiffness: 6.8 kPa (F1 by METAVIR) 1-Oct-2025 | N/A | Current Cigarette Use (15/day, 20 years) | Never used | Negative | Hepatosplenomegaly. Moderate gallbladder sludge, diffuse pancreatic changes | ||||||||
| BF19871171 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 30 Y | M | White | <-70C | 06-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 6-Oct-2025 | Height | 172 cm | Weight | 89 kg | $400.00 | Mean liver stiffness: 7.2 kPa (F1-F2 by METAVIR) 6-Oct-2025 | N/A | Current Cigarette Use (15/day, 10 years) | Never used | Negative | Signs of hepatosplenomegaly, cholesterolosis of the gallbladder, diffuse changes of the pancreas, focally altered areas in the spleen structure | ||||||||
| BF19871173 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 50 Y | M | White | <-70C | 02-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2-Oct-2025 | Height | 175 cm | Weight | 84 kg | $400.00 | Mean liver stiffness: 7.0 kPa (F1 by METAVIR) 2-Oct-2025 | N/A | Current Cigarette Use (15/day, 27 years) | Never used | Negative | Signs of hepatic steatosis and biliary sludge | ||||||||
| BF19871191 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 46 Y | M | White | <-70C | 21-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2022 | Height | 172 cm | Weight | 69 kg | $400.00 | Mean liver stiffness: 7.8 kPa (F2 by METAVIR) 20-Oct-2025 | Hypertension 2023 | Current Cigarette Use (15/day, 10 years) | Never used | Negative | |||||||||
| BF19871193 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 69 Y | F | White | <-70C | 24-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 24-Oct-2025 | Height | 164 cm | Weight | 80 kg | $400.00 | Mean liver stiffness: 8.65 kPa (F3 by METAVIR) 24-Oct-2025 | Ischemic heart disease; Heart failure; Hypertension; Diabetes mellitus type 2 2009; 2013; 2016; 2020 | Never used | Never used | Negative | |||||||||
| BF19871194 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 78 Y | F | White | <-70C | 21-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 21-Oct-2025 | Height | 155 cm | Weight | 75 kg | $400.00 | Mean liver stiffness: 7.15 kPa (F2 by METAVIR) 21-Oct-2025 | Ischemic heart disease; Hypertension; Diabetes mellitus type 2; Obesity class I 2000; 2005; 2015; 2020 | Never used | Never used | Negative | |||||||||
| BF19871197 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 39 Y | F | White | <-70C | 22-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 22-Oct-2025 | Height | 170 cm | Weight | 56 kg | $400.00 | Mean liver stiffness: 9.2 kPa (F3-4 by METAVIR) 22-Oct-2025 | Chronic pancreatitis 2018 | Never used | Never used | Negative | |||||||||
| BF19871221 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 37 Y | M | White | <-70C | 28-Mar-25 | BMI | 29.22 | Height | 185 cm | Weight | 100 kg. | $500.00 | Diffuse liver changes, Young's median is 5.88 KPa, which corresponds to F0-F1 on the METAVIR scale. Moderate steatosis. 28-Mar-25 | Metabolic dysfunction-associated steatohepatitis (MASH) 28-Mar-25 | Negative | Negative | Negative | Moderately enlarged liver, oblique vertical dimension of the right lobe of the liver 162 mm, thickness of the left lobe 78 mm The contours are even, the boundaries are clear. The structure of the parenchyma is heterogeneous due to periportal fibrosis | |||||||||
| BF19871230 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 65 Y | F | White | <-70C | 24-Feb-25 | BMI | 35.69 | Height | 164 cm | Weight | 96 kg. | $500.00 | The average value of the elasticity of the liver parenchyma is 6.0 kPa, which corresponds to F1 (on the scale METAVIR) 24-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2023 | Negative | Negative | Negative | N/A | |||||||||
| BF19871232 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 58 Y | M | White | <-70C | 14-Feb-25 | BMI | 25.73 | Height | 173 cm | Weight | 77 kg. | $500.00 | Oblique vertical size of the right lobe 171 mm, left lobe 80 mm. The structure is changed. K3 is 268 dB/m. Steatosis S2. Fatty degeneration is 51%. 3-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2017 | Negative | Negative | Negative | N/A | |||||||||
| BF19871235 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 43 Y | M | White | <-70C | 17-Feb-25 | BMI | 25.5 | Height | 176 cm | Weight | 79 kg. | $500.00 | Shape, structure of the liver is changed due to fatty degeneration. 60% fatty hepatosis. Steatosis S2. K3 is 280 dB/m 31-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2018 | Negative | Negative | Negative | N/A | |||||||||
| BF19871241 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 55 Y | M | White | <-70C | 12-Feb-25 | BMI | 28.39 | Height | 172 cm | Weight | 84 kg. | $500.00 | Oblique vertical size of the right lobe is 172 mm, the left lobe is 74 mm. The structure is changed, fatty degeneration is 50%. K3 is 265 dB/m. Steatosis S2. 23-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2012 | Negative | Negative | Negative | N/A | |||||||||
| BF19871245 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 54 Y | M | White | <-70C | 04-Mar-25 | BMI | 26.13 | Height | 166 cm | Weight | 72 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 6.0 kPa. On the METAVIR scale - F1. Moderate steatosis. 27-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 27-Feb-25 | Negative | Negative | Negative | The liver is not enlarged. The contours of the liver are even, the boundaries are clear. The structure of the parenchyma is heterogeneous. | |||||||||
| BF19871255 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 70 Y | F | White | <-70C | 20-Feb-25 | BMI | 27.68 | Height | 170 cm | Weight | 80 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 4.7 kPa. On the METAVIR scale - F0. 20-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2022 | Negative | Negative | Negative | N/A | |||||||||
| BF19871263 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 61 Y | M | White | <-70C | 27-Feb-25 | BMI | 35.43 | Height | 168 cm | Weight | 100 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 6.2 kPa. On the METAVIR scale - F1. Severe steatosis. 26-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 26-Feb-25 | Negative | Negative | Negative | The liver is enlarged, the contours are even and clear. The structure of the parenchyma is heterogeneous. | |||||||||
| BF19871264 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 38 Y | M | White | <-70C | 14-Feb-25 | BMI | 24.07 | Height | 180 cm | Weight | 78 kg. | $500.00 | Oblique vertical size of the right lobe is 175 mm, the left lobe is 76 mm. The structure is slightly changed, fatty degeneration is 48%. K3 is 262 dB/m. Steatosis S2. 24-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2020 | Negative | Negative | Negative | N/A | |||||||||
| BF19871265 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 58 Y | F | White | <-70C | 18-Feb-25 | BMI | 26.45 | Height | 165 cm | Weight | 72 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 5.5 kPa. On the METAVIR scale - F0. 18-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2024 | Negative | Negative | Negative | N/A | |||||||||
| BF19871269 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 54 Y | M | White | <-70C | 12-Feb-25 | BMI | 24.11 | Height | 174 cm | Weight | 73 kg. | $500.00 | Oblique vertical size of the right lobe is 177 mm, the left lobe is 77 mm. The structure is changed, fatty degeneration is 71%. K3 is 293 dB/m. Steatosis S3. 21-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2018 | Negative | Negative | Negative | N/A | |||||||||
| BF19871278 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 34 Y | M | White | <-70C | 14-Feb-25 | BMI | 29.41 | Height | 172 cm | Weight | 87 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 4.5 kPa. On the METAVIR scale - F0. 14-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2023 | Negative | Negative | Negative | N/A | |||||||||
| BF19871285 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 47 Y | M | White | <-70C | 14-Feb-25 | BMI | 25.43 | Height | 174 cm | Weight | 77 kg. | $500.00 | Oblique vertical size of the right lobe 169 mm, left lobe 70 mm. The structure is changed, fatty degeneration 68%. K3 is 292 dB/m. Steatosis S3. 30-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2020 | Negative | Negative | Negative | N/A | |||||||||
| BF19871331 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 45 Y | M | White | <-70C | 27-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 184 cm | Weight | 120 kg | $400.00 | Mean liver stiffness: 6.95 kPa (F1-F2 by METAVIR) 15-Oct-2025 | Diabetes mellitus type 2; Obesity class II 2008; 2004 | Never used | Never used | Negative | |||||||||
| BF19871332 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 48 Y | M | White | <-70C | 30-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 20-Oct-2025 | Height | 169 cm | Weight | 90 kg | $400.00 | Mean liver stiffness: 7.14 kPa (F1-F2 by METAVIR) 20-Oct-2025 | Obesity class I 2017 | Never used | Never used | Negative | |||||||||
| BF19871333 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 46 Y | M | White | <-70C | 27-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2022 | Height | 183 cm | Weight | 117 kg | $400.00 | Mean liver stiffness: 6.73 kPa (F1-F2 by METAVIR) 1-Oct-2025 | Obesity class I 2020 | Never used | Previous Use (1/day, 13 years, Quit in 2020) | Negative | |||||||||
| BF19871334 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 45 Y | M | White | <-70C | 22-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 173 cm | Weight | 89 kg | $400.00 | Mean liver stiffness: 6.97 kPa (F1-F2 by METAVIR) 22-Oct-2025 | Diabetes mellitus type 2 2005 | Never used | Never used | Negative | |||||||||
| BF19871341 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 65 Y | M | White | <-70C | 27-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 187 cm | Weight | 123 kg | $400.00 | Mean liver stiffness: 7.1 kPa (F1-F2 by METAVIR) 2-Oct-2025 | Diabetes mellitus type 2; Obesity class II 2010; 2005 | Never used | Never used | Negative | |||||||||
| BF19871342 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 65 Y | M | White | <-70C | 14-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2023 | Height | 178 cm | Weight | 135 kg | $400.00 | Mean liver stiffness: 7.14 kPa (F1-F2 by METAVIR) 3-Oct-2025 | Obesity class III 2002 | Never used | Never used | Negative | |||||||||
| BF19871343 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 35 Y | M | White | <-70C | 14-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 187 cm | Weight | 127 kg | $400.00 | Mean liver stiffness: 7.34 kPa (F1-F2 by METAVIR) 5-Oct-2025 | Diabetes mellitus type 2; Obesity class II 2010; 2018 | Never used | Never used | Negative | |||||||||
| BF19871344 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 53 Y | M | White | <-70C | 27-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2018 | Height | 190 cm | Weight | 110 kg | $400.00 | Mean liver stiffness: 7.0 kPa (F1-F2 by METAVIR) 1-Oct-2025 | Diabetes mellitus type 2; Obesity class I 2008; 2005 | Never used | Never used | Negative | |||||||||
| BF19871345 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 50 Y | M | White | <-70C | 22-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2023 | Height | 170 cm | Weight | 90 kg | $400.00 | Mean liver stiffness: 7.10 kPa (F1-F2 by METAVIR) 20-Oct-2025 | Obesity class I 2010 | Previous Cigarette Use (15/day, 20 years, Quit in 2017) | Previous Use (1/day, 20 years, Quit in 2018) | Negative | |||||||||
| BF19871346 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 51 Y | F | White | <-70C | 14-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2024 | Height | 168 cm | Weight | 99 kg | $400.00 | Mean liver stiffness: 6.94 kPa (F1-F2 by METAVIR) 29-Sep-2025 | Obesity class II 2010 | Never used | Previous Use (2/day, 8 years, Quit in 2015) | Negative | |||||||||
| BF19871351 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 43 Y | M | White | <-70C | 20-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 20-Oct-2025 | Height | 170 cm | Weight | 86 kg | $400.00 | Mean liver stiffness: 7.5 kPa (F2 by METAVIR) 20-Oct-2025 | N/A | Current Cigarette Use (15/day, 10 years) | Never used | Negative | |||||||||
| BF19871352 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 45 Y | M | White | <-70C | 14-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 14-Oct-2025 | Height | 169 cm | Weight | 87 kg | $400.00 | Mean liver stiffness: 7.8 kPa (F2 by METAVIR) 14-Oct-2025 | Obesity class I 2015 | Current Cigarette Use (15/day, 20 years) | Never used | Negative | |||||||||
| BF19871353 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 59 Y | F | White | <-70C | 16-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 16-Oct-2025 | Height | 167 cm | Weight | 76 kg | $400.00 | Mean liver stiffness: 7.2 kPa (F1-F2 by METAVIR) 16-Oct-2025 | Hypertension 2020 | Never used | Never used | Negative | |||||||||
| BF19871354 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 42 Y | M | White | <-70C | 20-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 20-Oct-2025 | Height | 171 cm | Weight | 89 kg | $400.00 | Mean liver stiffness: 7.2 kPa (F1-F2 by METAVIR) 20-Oct-2025 | Obesity class I 2018 | Current Cigarette Use (15/day, 13 years) | Never used | Negative | |||||||||
| BF19871355 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 63 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 15-Oct-2025 | Height | 176 cm | Weight | 82 kg | $400.00 | Mean liver stiffness: 6.8 kPa (F1 by METAVIR) 15-Oct-2025 | Heart failure 2016 | Current Cigarette Use (15/day, 35 years) | Never used | Negative | |||||||||
| BF19871364 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 12.00 | $400.00 | 50 Y | F | White | <-70C | 04-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 4-Nov-2025 | Height | 168 cm | Weight | 99 kg | $400.00 | Mean liver stiffness: 6.2 kPa (F1 by METAVIR) 4-Nov-2025 | Hypertension; Obesity class II; Chronic obstructive pulmonary disease 2016; 2015; 2010 | Never used | Never used | Negative | |||||||||
| BF19871365 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 55 Y | F | White | <-70C | 28-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 162 cm | Weight | 56 kg | $400.00 | Mean liver stiffness: 6.4-6.6 kPa (F1-F2 by METAVIR) 28-Oct-2025 | Psoriasis; Hypertension 2018; 2020 | Never used | Never used | Negative | |||||||||
| BF19871367 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 60 Y | M | White | <-70C | 06-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2021 | Height | 172 cm | Weight | 88 kg | $400.00 | Mean liver stiffness: 6.3 kPa (F1 by METAVIR) 6-Nov-2025 | Dilated cardiomyopathy. Heart failure; Chronic pancreatitis 2019; 2020 | Never used | Never used | Negative | |||||||||
| BF19871368 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 77 Y | F | White | <-70C | 06-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 6-Nov-2025 | Height | 165 cm | Weight | 82 kg | $400.00 | Mean liver stiffness: 8.7 kPa (F3 by METAVIR) 6-Nov-2025 | Hypertension; Obesity class I 2000; 2000 | Never used | Never used | Negative | |||||||||
| BF19871369 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 64 Y | M | White | <-70C | 05-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2008 | Height | 172 cm | Weight | 82 kg | $400.00 | Mean liver stiffness: 7.42 kPa (F2 by METAVIR) 5-Nov-2025 | Hypertension; Diabetes mellitus type 2 2010; 2015 | Never used | Never used | Negative | |||||||||
| BF19871370 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 13.00 | $400.00 | 66 Y | F | White | <-70C | 04-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 4-Nov-2025 | Height | 165 cm | Weight | 72 kg | $400.00 | Mean liver stiffness: 8.2 kPa (F3 by METAVIR) 4-Nov-2025 | Hypertension 2016 | Never used | Never used | Negative | |||||||||
| BF19871371 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 76 Y | F | White | <-70C | 05-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2022 | Height | 164 cm | Weight | 86 kg | $400.00 | Mean liver stiffness: 8.8 kPa (F3 by METAVIR) 5-Nov-2025 | Hypertension; Diabetes mellitus type 2; Obesity class I 2001; 2008; 2005 | Never used | Never used | Negative | |||||||||
| BF19871372 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 69 Y | M | White | <-70C | 05-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2023 | Height | 184 cm | Weight | 86 kg | $400.00 | Mean liver stiffness: 6.35 kPa (F1 by METAVIR) 5-Nov-2025 | Diabetes mellitus type 2; Hypertension; Ischemic heart disease; Heart failure; Atrial fibrillation, permanent form; Chronic obstructive pulmonary disease; Pulmonary emphysema 2015; 2005; 2005; 2012; 2015; 2015; 2015 | Never used | Never used | Negative | |||||||||
| BF19871373 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 13.00 | $400.00 | 73 Y | F | White | <-70C | 06-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 6-Nov-2025 | Height | 168 cm | Weight | 110 kg | $400.00 | Mean liver stiffness: 8.95 kPa (F3 by METAVIR) 6-Nov-2025 | Hypertension; Diabetes mellitus type 2; Chronical bronchitis; Obesity class II 2005; 2015; 2017; 2011 | Never used | Never used | Negative | |||||||||
| BF19871374 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 55 Y | M | White | <-70C | 03-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2023 | Height | 173 cm | Weight | 100 kg | $400.00 | Mean liver stiffness: 7.41 kPa (F1-F2 by METAVIR) 2-Sep-2025 | Obesity class I 2010 | Previous Cigarette Use (15/day, 15 years, Quit in 2008) | Previous Use (2/day, 15 years, Quit in 2010) | Negative | |||||||||
| BF19871375 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 58 Y | F | White | <-70C | 03-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 160 cm | Weight | 90 kg | $400.00 | Mean liver stiffness: 6.85 kPa (F1-F2 by METAVIR) 26-Sep-2025 | Diabetes mellitus type 2; Obesity class II 2010; 2016 | Never used | Never used | Negative |